Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Have a Diagnosis of Coronary Artery Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Post-approval studies (Phase 4)Study completedNCT02415400
What this trial is testing

Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

Who this might be right for
Acute Coronary Syndromes
Bristol-Myers Squibb 4,614
Large-scale testing (Phase 3)Study completedNCT00251576
What this trial is testing

Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack (0733-180)

Who this might be right for
Acute Coronary Syndrome
Organon and Co 4,497
Not applicableUnknownNCT04787796
What this trial is testing

The Application of a Portable Multichannel ECG System for the Patients Suspected to Have Possible CAD or ACS

Who this might be right for
CAD
National Taiwan University Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT06927739
What this trial is testing

Focused Orticumab Research for Treating Inflammation in Coronary Arteries

Who this might be right for
Acute Coronary SyndromesCoronary Arterial Disease (CAD)Inflammation+3 more
Abcentra 240
Large-scale testing (Phase 3)Looking for participantsNCT07613294
What this trial is testing

See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk

Who this might be right for
AtherosclerosisCardiovascular DiseasesLipoprotein(a)
Eli Lilly and Company 252
Not applicableStudy completedNCT02077218
What this trial is testing

Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant

Who this might be right for
Cancer SurvivorDiabetes MellitusHypertension
City of Hope Medical Center 20
Not applicableStudy completedNCT02922543
What this trial is testing

A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use

Who this might be right for
Multiple Myeloma
Celgene 361
Not applicableStudy completedNCT01276132
What this trial is testing

Patient Satisfaction and Safety Outcomes After Enrollment in a Same-Day (SD) Percutaneous Coronary Intervention Program

Who this might be right for
To Evaluate Clinical Outcomes, Safety, and Satisfaction of Patients Who Have Participated in a Same Day Outpatient Percutaneous Coronary Artery Intervention
University of Chicago 59
Not applicableUnknownNCT03736018
What this trial is testing

Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients

Who this might be right for
Ischaemic Heart DiseaseContrast-induced Nephropathy
Queen Mary University of London 688
Not applicableStudy completedNCT05715879
What this trial is testing

Covid-19 Infection and Long-term Cardiovascular Symptoms

Who this might be right for
COVID-19 PandemicDyspnea; CardiacChest Syndrome+1 more
Shiraz University of Medical Sciences 879